Schizophrenia Research
Volume 76, Issue 1 , Pages 127-129 , 1 July 2005

Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation

Received 26 May 2004

References 

  1. Honigfeld G. Nosie-30: history and current status of its use in pharmacopsychiatric research. Mod. Probl. Pharmacopsychiatry. 1974;7:238–263
  2. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987;13:261–276
  3. Volavka J, Czobor P, Sheitman B, Lindenmayer J-P, Citrome L, McEvoy J, et al. Clozapine, olanzapine, risperidone, and haloperidol in treatment-resistant patients with schizophrenia and schizoaffective disorder. Am. J. Psychiatry. 2002;159:255–262

PII: S0920-9964(04)00439-6

doi: 10.1016/j.schres.2004.11.007

Schizophrenia Research
Volume 76, Issue 1 , Pages 127-129 , 1 July 2005

Article Tools